New technology to streamline drug discovery

09-Oct-2019 - George Mason University researchers have discovered the exact location where two proteins responsible for hiding cancer cells from the immune system bind. This discovery provides a novel approach to developing new cancer immunotherapy medicines that can be administered as a pill, compared to ...

Mixed chemicals in beauty products may harm women's hormones

18-Sep-2018 - As we go about our daily lives, we are exposed to many different chemicals that could have negative effects on our hormones. These hormonal changes have been linked to several adverse health outcomes such as breast cancer and cardiovascular disease. Therefore, understanding chemicals that ...

New 'trick' allows HIV to overcome a barrier to infection

08-Sep-2008 - Researchers have discovered a new 'trick' that allows HIV to overtake resting T cells that are normally highly resistant to HIV infection, according to a report in Cell, a Cell Press publication. The binding of the virus to the surface of those cells sends a signal that breaks down the cells' ...

Thermo Fisher Scientific and George Mason University Partner in Protein Biomarker Research Project

Collaboration Aims to Accelerate Verification and Validation of Protein Biomarkers for Earlier Disease Diagnosis and Therapeutic Efficacy

30-May-2008 - Thermo Fisher Scientific Inc. announced an alliance between its Biomarker Research Initiatives in Mass Spectrometry (BRIMS) Center and George Mason University's Center for Applied Proteomics and Molecular Medicine (CAPMM) to accelerate biomarker validation and forge new breakthroughs in early ...

PerkinElmer and George Mason University Announce Alliance to Develop Novel Proteomic Technologies

Biomarker Identification for Early Cancer Detection

30-Mar-2006 - PerkinElmer, Inc. announced a five-year research collaboration agreement with George Mason University to develop a new and innovative approach for cancer detection and risk stratification. Scientists from both organizations will work together on the design of several new types of clinical assay ...